Washington
+919359902383
+919359902383

Sugistran 50mg Sunitinib Capsules USA | Ernest Impex Exporter from India

Product Information: Sugistran 50mg Capsules


Sugistran 50mg Capsule is an orally active multi-targeted small-molecule tyrosine kinase inhibitor (TKI) containing Sunitinib Malate equivalent to 50mg of sunitinib. Engineered to halt advanced solid tumor progression, this molecule dynamically blocks multiple receptor tyrosine kinases (RTKs) involved in tumor growth, pathologic angiogenesis, and metastatic progression. It plays a critical role in standard global protocols for specific renal, gastrointestinal, pancreatic, and medullary thyroid malignancies.



1. Indications & Usage

Sugistran 50mg Capsules are indicated primarily under strict professional medical, clinical research, and specialist oncology supervision for:

  • Advanced Renal Cell Carcinoma (RCC): Prescribed for the systemic treatment of advanced or metastatic renal cell carcinoma to control the growth of cancerous cells within the kidney.

  • Gastrointestinal Stromal Tumor (GIST): Indicated for the treatment of gastrointestinal stromal tumors that form in the digestive tract, especially after disease progression on or intolerance to imatinib mesylate.

  • Pancreatic Neuroendocrine Tumors (pNET): Administered for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease.

  • Medullary Thyroid Cancer: Indicated in specific advanced protocols for treating malignancies originating in the thyroid gland.


2. Mechanism of Action: Multi-Kinase & Angiogenesis Inhibition

Sunitinib stops oncogenic cellular duplication and vascular blood supply tracking through precise target receptor blockade:

  • Simultaneous RTK Inhibition: Sugistran targets and binds to multiple receptor tyrosine kinases, specifically blocking vascular endothelial growth factor receptors (VEGFR) and platelet-derived growth factor receptors (PDGFR) responsible for cancer propagation.

  • Angiogenesis Arrest: By shutting down downstream VEGFR signaling pathways within endothelial cells, it restricts the growth of new blood vessels, starving the tumor matrix of essential oxygen and blood supply.

  • Tumor Microenvironment Disruption: It permanently interrupts intracellular proliferation cascades, minimizing the spread of abnormal cells and inducing tumor apoptosis.


3. Storage, Stability & Commercial Packaging Specifications

  • Temperature Maintenance: Store in a dry, cool environment below 30Β°C. Protect shipments from prolonged thermal spikes, moisture vapor transmission, and direct ambient ultraviolet sunlight.

  • Commercial Integrity: Packed in heavy-duty commercial configurations (such as standard 28-capsule institutional bottles or blister formats) designed to withstand long-range transit variables safely.

  • Safety Protocol: Keep strictly out of the sight and reach of children. Capsules must be swallowed whole; do not break, chew, open, or crush them.


4. Safety Profile, Side Effects, and Clinical Monitoring

Because Sugistran is a highly potent antineoplastic agent, ongoing specialist clinical monitoring is mandatory to protect patient safety.

  • Common Side Effects: Fatigue, weakness, diarrhea, nausea, vomiting, mouth sores (stomatitis), changes in taste, and decreased appetite.

  • Cardiovascular & Hypertension Risks: Regular blood pressure monitoring is necessary, as the drug can cause severe hypertension. Evaluating cardiac safety and left ventricular function is strongly advised.

  • Dermatological & Healing Alterations: Patients may experience skin discoloration (yellowing or lightening), hair loss, dryness, and hand-foot syndrome (redness/blistering on palms and soles). It can also delay wound healing time.

  • Systemic Monitoring: Periodic clinical evaluation of thyroid gland function, liver enzymes, and complete blood counts is required to check for myelosuppression, bleeding issues, or organ toxicity.


5. Regulatory and Compliance Documentation

ERNEST IMPEX ensures that every trade lane shipment of Sugistran 50mg complies with strict international customs and medical export expectations by providing:

  • Comprehensive Commercial Invoice & Itemized Packing Lists

  • Validated Certificates of Analysis (CoA) from approved laboratories

  • Legalized Export Documentation (IEC & Custom shipping clearance data)

  • Secure, temperature-shielded freight layout for air or cargo routing


πŸ’‘ Why Choose ERNEST IMPEX?

  • Direct sourcing channels from verified manufacturing infrastructure in India

  • Scale-ready capacity for hospital groups, clinical distributors, and regional wholesalers

  • Precision documentation routing for transparent customs tracking

  • Dedicated global trade desks providing end-to-end support


PRESCRIPTION MEDICINE: YES

Sugistran 50mg Capsules must be supplied and administered strictly under the authority of a registered professional. The clinical and pharmacological data listed here serves strictly as a commercial guide for international bulk procurement, regulatory compliance matching, and wholesale trade awareness.



πŸ“ž Contact Ernest Impex β€” Pharmaceutical Exporter from India

[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]


🌐 Websites:


www.ernestimpex.com
www.ernestvision.com
www.oncologymedicinesupplier.com
www.ernestpharmaceuticals.com


πŸ“§ Corporate Email: exports@ernestpharmaceuticals.com
πŸ“¦ Business Type: Exporter | Bulk Supplier | Distributor
πŸ“² WhatsApp: +91 93599 02383
πŸ”— Instant Chat Link: Click to Chat on WhatsApp

 2026-06-15T09:22:43

Keywords